Journal of Cranio-Maxillo-Facial Surgery
Volume 38, Issue 4 , Pages 288-292, June 2010

A comparison of bone reconstruction following application of bone matrix gelatin and autogenous bone grafts to alveolar defects: An animal study

  • Mohammad Bayat, OMFS, DDS

      Affiliations

    • Department of Oral and Maxillofacial Surgery, School of Dentistry, Dental Research Centre, Tehran University of Medical Sciences, Tehran, Iran
    • Corresponding Author InformationMohammad BAYAT, DDS, OMFS, Assistant Professor of Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, Dental Research Centre, Tehran University of Medical Sciences, Enghelab Ave., Tehran, Iran. Tel.: +98 9121481979; Fax: +98 2188777073.
  • ,
  • Fatemeh Momen-Heravi, DDS

      Affiliations

    • School of Dentistry, Dental Research Centre, Tehran University of Medical Sciences, Tehran, Iran
  • ,
  • Mehdi Marjani, DVM, PhD

      Affiliations

    • Department of Clinical Sciences, School of Veterinary Medicine, Karaj Branch, Islamic Azad University, Karaj, Iran
  • ,
  • Pouria Motahhary, MS, DDS

      Affiliations

    • Department of Oral and Maxillofacial Pathology, School of Dentistry, Tehran University of Medical Sciences, Tehran, Iran

Received 22 April 2009; accepted 5 October 2009. published online 12 November 2009.

Summary 

The aim of this study was to compare the quantity and quality of osseous healing of bone matrix gelatin (BMG) with autogenous bone graft (ABG) in cat models. Osseous defects (5×5mm) were made through upper alveolar bone distal to the canines in the left and right quadrants (maxilla) in each of twelve Persian male cats and filled randomly with BMG and ABG. The repair response was examined on days 14, 28, and 56 after surgery (n=4 per bone substitute per time point). Qualitative histological and quantitative histometric analysis including percentage of new formed bone fill (BF) and density were done. The inter-treatment comparison of mean levels of BF at specific time points showed consistently greater levels within BMG treated defects and reached significance on days 14, 28, and 56 (P<0.05). Regarding bone density (BD), there was no significant difference between BMG and ABG on days 14 and 28 (P>0.05). On day 56, BD was significantly higher within BMG group (P<0.05). Intra-treatment evaluation of bone formation in each group showed that BD significantly increased during treatment (P<0.05), and BF in BMG group reached significance at every time point but in ABG group only increase from day 28 to 56 reached significance (P<0. 05). Our results support the use of BMG to treat bone defects. Clinicians might expect better clinical outcomes without the possibility of side effects and morbidity associated with the harvest of autogenous bone.

Keywords: autogenous bone graft, bone healing, bone matrix gelatin, bone morphogenic protein, osteoinductive materials

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1010-5182(09)00167-X

doi:10.1016/j.jcms.2009.10.003

Journal of Cranio-Maxillo-Facial Surgery
Volume 38, Issue 4 , Pages 288-292, June 2010